Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.H Lundbeck has extended its agreement with Medidata Solutions, a provider of SaaS-based clinical development solutions, to use the Medidata Rave electronic data capture (EDC) and clinical data management (CDM) platform for another multi-year period, building on the relationship in the initial three-year contract.
Subscribe to our email newsletter
Medidata Solutions said that Rave was selected by H Lundbeck initially in 2007 as an EDC system based on its ability to handle large and complex studies and its collaboration-enabling data collection, management and reporting capabilities.
Since then, H Lundbeck has used Medidata Rave in all Phase II–III clinical studies. The new multi-year contract allows for Rave use in all H Lundbeck’s upcoming Phases II and III trials.
Tarek Sherif, chairman and CEO of Medidata Solutions, said: “We have developed a strong partnership with H Lundbeck over the past two years and are proud to continue to support the company’s pipeline of CNS therapies.”
H Lundbeck is an international pharmaceutical company engaged in the research and development, production, marketing and sale of pharmaceuticals across the world, targeted at disorders like depression and anxiety, schizophrenia, insomnia, Huntington’s, Alzheimer’s and Parkinson’s diseases.